We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$377B
AUM Growth
+$49.7B
Cap. Flow
+$31.3B
Cap. Flow %
8.3%
Top 10 Hldgs %
41.14%
Holding
5,593
New
785
Increased
2,954
Reduced
1,009
Closed
322

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Financials 7.13%
3 Consumer Discretionary 6.46%
4 Healthcare 5.43%
5 Communication Services 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDSB icon
5251
PDS Biotechnology
PDSB
$36.7M
-1
Closed -$3
PGY icon
5252
Pagaya Technologies
PGY
$1.37B
-21,304
Closed -$272K
PIII icon
5253
P3 Health Partners
PIII
$38M
-352
Closed -$7.93K
PLCE icon
5254
Children's Place
PLCE
$54M
-3,065
Closed -$27.1K
POR icon
5255
CALL
Portland General Electric
POR
$5.89B
-93,500
Closed -$4.04M
PTEN icon
5256
CALL
Patterson-UTI
PTEN
$3.57B
-8,520,000
Closed -$88.3M
RARE icon
5257
CALL
Ultragenyx Pharmaceutical
RARE
$2.5B
-174,000
Closed -$7.15M
RBOT
5258
DELISTED
Vicarious Surgical
RBOT
-401
Closed -$2.35K
RGEN icon
5259
CALL
Repligen
RGEN
$7.05B
-121,000
Closed -$15.3M
RGR icon
5260
CALL
Sturm, Ruger & Co
RGR
$606M
-31,300
Closed -$1.3M
RGS icon
5261
Regis Corp
RGS
$68.1M
-6
Closed -$138
RIG icon
5262
CALL
Transocean
RIG
$5.43B
-240,000
Closed -$1.28M
RILY icon
5263
CALL
BRC Group Holdings
RILY
$258M
-24,200
Closed -$427K
RNAM
5264
CALL
DELISTED
Avidity Biosciences
RNAM
-60,000
Closed -$2.45M
ROST icon
5265
CALL
Ross Stores
ROST
$80.9B
-10,100
Closed -$1.47M
RXRX icon
5266
CALL
Recursion Pharmaceuticals
RXRX
$1.57B
-60,000
Closed -$450K
RYAAY icon
5267
Ryanair
RYAAY
$29.9B
-5,725
Closed -$267K
RYTM icon
5268
CALL
Rhythm Pharmaceuticals
RYTM
$7.34B
-5,600
Closed -$230K
SABR icon
5269
CALL
Sabre
SABR
$727M
-100,000
Closed -$267K
SAGE
5270
CALL
DELISTED
Sage Therapeutics
SAGE
-60,000
Closed -$652K
SDA icon
5271
SunCar Technology Group
SDA
$77.4M
-600
Closed -$5.47K
SDS icon
5272
ProShares UltraShort S&P500
SDS
$431M
-200
Closed -$23K
SE icon
5273
CALL
Sea Limited
SE
$66B
-50,000
Closed -$3.57M
SEDG icon
5274
CALL
SolarEdge
SEDG
$2.35B
-20,000
Closed -$505K
SG icon
5275
CALL
Sweetgreen
SG
$763M
-180,000
Closed -$5.43M

Similar funds

Barclays's Q3 2024 Portfolio in Review

As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.

  • Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
  • Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
  • Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
  • Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
  • Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
  • Barclays opened 785 new positions and closed 322 in Q3 2024.
  • Barclays's portfolio value rose 15% quarter-over-quarter to $377B.

Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.